John T. Kilcoyne serves as Executive at MICRUS ENDOVASCULAR CORP, where they oversee executive responsibilities. Since joining the company, John T. Kilcoyne has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 27, 2010 involved selling 8,056 shares valued at $0.
John T. Kilcoyne currently holds 6,410 shares of MICRUS ENDOVASCULAR CORP (MEND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John T. Kilcoyne has been a net neutral trader of MEND stock. They have purchased $0 and sold $0 worth of shares.
John T. Kilcoyne's most recent insider trade was on Sep 27, 2010, when they sold 8,056 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |